Home > Healthcare > Pharmaceuticals > Finished Drug Form > Stomach Cancer Treatment Market
Stomach Cancer Treatment Market Size
- Report ID: GMI10227
- Published Date: Jul 2024
- Report Format: PDF
Stomach Cancer Treatment Market Size
Stomach cancer treatment market size was valued at around USD 4.7 billion in 2023 and is estimated to grow at 13.5% CAGR from 2024 to 2032. Stomach cancer, also known as gastric cancer, is a type of cancer that begins in the stomach's lining. Treatment options include surgery (partial or total gastrectomy and lymphadenectomy), radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Palliative care is also essential for managing symptoms in advanced stages.
The rising incidence of stomach cancer is a significant driver for the market. For instance, according to World Cancer Research Fund International, the stomach cancer was the fifth most common cancer globally in 2022. It ranked as the fourth most common cancer in men and the seventh in women. Moreover, there were over 968,784 new cases of stomach cancer reported worldwide in 2022. Therefore, this underscores the critical need for advanced diagnostic and treatment solutions to address the growing prevalence of stomach cancer and improve patient outcomes.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Stomach Cancer Treatment Market Size in 2023: | USD 4.7 Billion |
| Forecast Period: | 2024-2032 |
| Forecast Period 2024-2032 CAGR: | 13.5% |
| 2032 Value Projection: | USD 14.4 Billion |
| Historical Data for: | 2021-2023 |
| No. of Pages: | 281 |
| Tables, Charts & Figures: | 341 |
| Segments covered: | Type, Indication, Drug Class, Route of Administration, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Furthermore, advancements in diagnostic techniques, development of targeted therapies, rising awareness and screening programs, are the factors promoting the growth of the market.
Frequently Asked Questions (FAQ) :
Stomach Cancer Treatment Market Scope
